Interferon beta in severe acute respiratory syndrome (sars)

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61K 31/7056 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2521650

The use of an interferon (IFN) for the manufacture of a medicament useful for treatment and/or prevention of Severe Acute Respiratory Syndrome (SARS) is described in the present invention.

L'invention concerne l'utilisation d'un interféron (IFN) pour la fabrication d'un médicament utilisé dans le traitement et/ou la prévention du syndrome respiratoire aigu sévère (SRAS).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Interferon beta in severe acute respiratory syndrome (sars) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interferon beta in severe acute respiratory syndrome (sars), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon beta in severe acute respiratory syndrome (sars) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1571596

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.